
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+19
Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure certain cancers and rare diseases. The Companys pipeline includes investigational allogeneic CAR-T cell therapies for both solid tumors and hematologic cancers as well as investigational in vivo genetic medicines that address patient populations with high unmet medical need. The Companys approach is based on its proprietary genetic editing platforms, including its non-viral piggyBac DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. The Company has formed...
Genome engineering,car-t cells,gene therapy,gene editing,cell therapy,adoptive cell therapy,multiple myeloma,prostate cancer,transposon,non-viral,biotechnology,immunotherapy,regenerative medicine,t-cells,allogeneic,oncology,immuno-oncology,immunology,poseida,cytotoxic t lymphocytes,piggybac®,piggybac® dna modification system,cas-clover™,and tal-clover™
Poseida therapeutics, inc operates in the Biotechnology research industry.
Poseida therapeutics, inc's revenue is 101m - 500m
Poseida therapeutics, inc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.